Healthtech funding in Q2 2025
European Healthtech startup funding raised during Q2 2025.
In Q2 2025, 127 European Healthtech companies closed 127 funding rounds and raised €1.5B in equity funding (excluding debt and grants), up 12.1% versus Q2 2024. Debt rounds added €20M. Switzerland led by capital raised, and Venture Kick was the most active investor. Data as of 20 Nov 2026.
Equity funding
€1.5B
+12.1% vs Q2 2024 · excl. debt & grants · +€20M debt
Funding rounds
127
+28.3% vs Q2 2024
Companies
127
Top country
Switzerland
Rank among sectors
#4
9.9% of sector funding
Debt financing
€20M
1.3% of total
Top-10 round share
59.3%
of disclosed capital
Rounds ≥ €100M
4
Funding by month
€ raised vs rounds, by monthHealthtech — funding by month, Q2 2025 — interactive chart.
Data table
| Funding | Rounds | |
|---|---|---|
| Apr | €427M | 39 |
| May | €739M | 47 |
| Jun | €360M | 41 |
Top countries
by € raisedHealthtech — top countries by capital, Q2 2025 — interactive chart.
Data table
| Healthtech — top countries by capital, Q2 2025 | |
|---|---|
| Switzerland | €381M |
| UK | €338M |
| Netherlands | €256M |
| Spain | €188M |
| France | €111M |
| Finland | €72M |
| Germany | €53M |
| Portugal | €35M |
Stage mix
by € raisedHealthtech — stage mix, Q2 2025 — interactive chart.
Data table
| Healthtech — stage mix, Q2 2025 | |
|---|---|
| Series B | €583M |
| Other | €443M |
| Series A | €270M |
| Series C | €85M |
| Seed | €71M |
| Grant | €38M |
| Debt | €20M |
| Pre-Seed | €10M |
| Early VC | €2.1M |
| Growth/Late | €2.0M |
| Crowdfunding | €460k |
Exits & M&A
8 Acquisition8 exits.
Top deals
largest disclosed rounds in Q2 2025| Company | Stage | Date | Amount |
|---|---|---|---|
| CMR Surgical | Other | Apr 2025 | €185M |
| Azafaros | Series B | May 2025 | €132M |
| SpliceBio | Series B | Jun 2025 | €118M |
| GlycoEra | Series B | May 2025 | €114M |
| Mosanna Therapeutics | Series A | Jun 2025 | €70M |
| Juvenescence | Series B | May 2025 | €67M |
| haya therapeutics | Series A | May 2025 | €58M |
| ReproNovo | Series A | May 2025 | €57M |
| Salvia BioElectronics | Series B | May 2025 | €53M |
| Deepull | Series C | Apr 2025 | €50M |
| Hilo (Aktiia) | Series B | May 2025 | €37M |
| SafeHeal | Series C | May 2025 | €35M |
| Sword Health | Other | Jun 2025 | €35M |
| IXI | Series A | Apr 2025 | €32M |
| Clinomic | Other | Apr 2025 | €23M |
Top investors
most active in Q2 2025, by deal count- Venture Kick5 deals
- Business Finland3 deals
- Sofinnova Partners3 deals
- Verve Ventures3 deals
- Voima Ventures3 deals
- Ahren Innovation Capital2 deals
- Asabys Partners2 deals
- better ventures2 deals
- BNP Paribas Développement2 deals
- Brabant Development Agency (BOM)2 deals